Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive forms of cancer.
It grows and spreads rapidly, and sadly, the survival rate is quite low, with only 8% of patients living beyond five years after diagnosis. This grim reality has motivated scientists to search for more effective treatments.
Breakthrough Research at the Francis Crick Institute
A team of researchers at the Francis Crick Institute, led by Axel Behrens, has made a potentially groundbreaking discovery, as reported in Nature Cell Biology. Their focus? Cancer stem cells in PDAC.
Cancer stem cells are unique because they can initiate new tumors and transform into various tumor cell types. Understanding these cells is crucial for developing new cancer treatments.
The Role of the CD9 Protein
In their research, the team identified a protein called CD9, present on the surface of cancer stem cells in PDAC. This protein is important for two reasons:
Marker for Cancer Stem Cells: CD9 serves as a marker to identify these cells, whether in early or advanced stages of tumor growth.
Influencing Cancer Aggressiveness: The amount of CD9 in cancer cells influences the severity of the disease. Decreasing CD9 leads to smaller tumors, while increasing it results in more aggressive cancer growth.
The Link Between CD9 and Patient Prognosis
Clinical data indicates that patients with higher levels of CD9 in their tumor cells often have a poorer prognosis. About 10% of PDAC patients exhibit high CD9 levels.
The team discovered that CD9 accelerates the intake of a nutrient called glutamine by cancer stem cells. This nutrient is like fuel for cancer, aiding its growth and proliferation.
Potential New Treatments
The discovery of CD9’s role in PDAC opens up exciting new possibilities for treatment. Therapies targeting CD9 could potentially disrupt the cancer cells’ nutrient supply, essentially starving them.
This approach could lead to more effective treatments for PDAC, offering hope to many patients.
Looking to the Future
While more research is needed, targeting CD9 represents a significant advancement in the battle against pancreatic cancer.
This new approach could revolutionize treatment strategies and improve survival rates for patients with this devastating disease.
If you care about cancer, please read studies about a new method to treat cancer effectively, and this low-dose, four-drug combo may block cancer spread.
For more information about cancer prevention, please see recent studies about nutrient in fish that can be a poison for cancer, and results showing this daily vitamin is critical to cancer prevention.
Copyright © 2023 Knowridge Science Report. All rights reserved.
